environment and the impact of government pressures; risks involved in doing business on an international level, including currency risks, regulatory requirements, political risks, export restrictions and other trade barriers; the Company's production capacity, efficiency and supply constraints; and other risks detailed in the Company's press releases, shareholder communications and Securities and Exchange Commission filings, including the Company's Form 10-K for the year ended September 30, 2012. Actual events affecting the Company and the impact of such events on the Company's operations may vary from those currently anticipated.
For more information about the Female Health Company visit the Company's website at www.femalehealth.com and www.femalecondom.org. To be added to the Company's e-mail alert list, please send an e-mail to FHCInvestor@femalehealthcompany.com.
(Financial Highlights Follow)
The Female Health CompanyUnaudited Condensed Consolidated Balance Sheets September 30,20122011Cash
$
5,290,780$
4,249,324Certificate of deposit
-63,875Restricted cash
4,6824,526Accounts receivable, net
7,268,9172,305,473Income tax receivable
27,369-Inventories
1,458,1992,026,528Prepaid expenses and other current assets
624,268297,267Deferred income taxes
2,152,000800,000Total current assets
16,826,2159,746,993Other non-current assets
122,336116,360Plant and equipment, net
2,349,8761,979,438Deferred income taxes
11,148,0007,600,000Total assets
$
30,446,427$
9,442,791Accounts payable
$
,775,327$
,076,994Accrued expenses and other current liabilities
1,120,302846,591Accrued compensation
2,964,812369,825Total current liabilities
'/>"/>SOURCE The Female Health Company Copyright©2012 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 Related medicine technology :1.
The Female Health Company to Report FY2012 Operating Results on Tuesday, December 4, 20122.
Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial3.
Attorneys for Class of Female VPs and SVPs Employed by PR Giant MSLGroup Clarify Companys Inaccurate Description of Federal Courts Recent Certification Ruling4.
The Female Health Company Reports Second Quarter Operating Results5.
Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement6.
Depomed To Present At Oppenheimer 2012 Healthcare Conference7.
Premier Healthcare Alliance Awards 3-Year Group Purchasing Contract for Diaper and Adult Brief Waste Receptacles to Sinclair Worldwide8.
U.S. News & World Report and Pharmacy Times Introduce New Pharmacist-recommended Health Product Website9.
ClinicalKey Key Innovator Award to Recognize the Innovative Use of Health Information and Technology to Save and Improve Lives10.
Frost & Sullivan: Investments in Healthcare Improvements to Bolster the Integration of Picture Archiving and Communications Systems in Latin America11.
Affluence, an Aging Population, and Anticipated Rx-to-OTC Switches Boost a Healthy $32 Billion OTC Market in China, According to Kline